Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal. (Q44567442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

María A Aguilar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

C Maldonado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Rodríguez-Arias

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Miñarro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

Behavioural Brain Research

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

25-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Dopamine D1-like receptors and reward-related incentive learning.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Heroin reward is dependent on a dopaminergic substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Ethological analysis of morphine withdrawal with different dependence programs in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Behavioral interactions caused by combined administration of morphine and MK-801 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Possible abuse potential of the NMDA antagonist MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The role of dopamine in drug abuse viewed from the perspective of its role in motivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Effects of haloperidol in a response-reinstatement model of heroin relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: II. Morphine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

6-OHDA lesions of the ventral tegmental area block morphine-induced but not amphetamine-induced facilitation of self-stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Mode of binding of [3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Previous chronic blockade of NMDA receptors intensifies morphine dependence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Subchronic administration of MK-801 in the rat decreases cortical binding of [3H]D-AP5, suggesting down-regulation of the cortical N-methyl-D-aspartate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Under siege: The brain on opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Glutamate receptors in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Strategies for studying the neurochemical substrates of drug reinforcement in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Dopamine receptor agonists, partial agonists and psychostimulant addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Supersensitivity of cortical neurones of the rat to acetylcholine and L-glutamate following chronic morphine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat--a pharmacokinetic microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Neurobiology of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

Infusion of (+) -MK-801 and memantine -- contrasting effects on radial maze learning in rats with entorhinal cortex lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900044-5

7 January 2021

10.1016/S0166-4328(03)00044-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946592%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference